Weizhen Huang

860 citations
36 papers · 632 indexed · h-index 15
Topics
Circular RNAs in diseases (5 papers)MicroRNA in disease regulation (4 papers)Cancer-related molecular mechanisms research (4 papers)

In The Last Decade

Weizhen Huang

32 papers receiving 623 citations

Peers

Weizhen Huang
Comparison fields: 5 of 96
  • Molecular Biology 332
  • Cancer Research 164
  • Plant Science 98
  • Pharmacology 69
  • Oncology 63
Replace Jinyan Zhao with:
Jinyan Zhao China
Gongcheng Wang China
Jianping Gao China
Gi Dae Kim South Korea
Rui Deng China
Zhaojing Wang China
Ken Kuroda Japan
Chien‐Ho Chen Taiwan
Qingtao Lv China
Jingyi Song China
Weizhen Huang relative to Jinyan Zhao China Jinyan Zhao's profile →
Citations per field
00.5×1.5×
Jinyan Zhao · 1×
Citations per year

Countries citing papers authored by Weizhen Huang

Since Specialization
Citations

This map shows the geographic impact of Weizhen Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weizhen Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weizhen Huang more than expected).

Fields of papers citing papers by Weizhen Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weizhen Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weizhen Huang. The network helps show where Weizhen Huang may publish in the future.

Co-authorship network of co-authors of Weizhen Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Weizhen Huang. A scholar is included among the top collaborators of Weizhen Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weizhen Huang. Weizhen Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 0
3 0
4 16
5 0
6 6
7 0
8 8
9 9
10 1
11 22
12 4
13 21
14 54
15
Changes of BFGF and VEGF in patients with ischemic stroke treated by acupuncture-moxibustion with du channel-unblocking acupuncture method
1
16 87
17 10
18 44
19 73
20 17

About Weizhen Huang

Weizhen Huang is a scholar working on Cancer Research, Pharmacology and Biochemistry, having authored 36 papers that have together received 632 indexed citations. Recurring topics across this work include Circular RNAs in diseases (5 papers), MicroRNA in disease regulation (4 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Cancer Research (164 citations), Pharmacology (69 citations) and Molecular Biology (332 citations). Weizhen Huang has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Zhongxi Zhao, Siying Li, Yongjie Wang, Xiaohong Guo, Hanqi Zhuang, Jie Wu, Xiaoyan Jiang, Min Yang, Yunming Tian and Yuan Xia. Their work appears in journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026